Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary

Conclusion Persistence in this study was in the published range of observational MS studies. Furthermore, in male patients continuation of therapy might be positively influenced by use of a PDA, and both female and male patients might benefit from an integrated reminder function. In conclusion, electronic diaries reminding patients of upcoming injections can promote an improved adherence to MS therapy. Trial registration ClinicalTrials.gov identifier: NCT00902135. Funding Bayer Vital GmbH.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research